mTOR as a Key Regulator in Maintaining Skeletal Muscle Mass - PubMed (original) (raw)

Review

mTOR as a Key Regulator in Maintaining Skeletal Muscle Mass

Mee-Sup Yoon. Front Physiol. 2017.

Abstract

Maintenance of skeletal muscle mass is regulated by the balance between anabolic and catabolic processes. Mammalian target of rapamycin (mTOR) is an evolutionarily conserved serine/threonine kinase, and is known to play vital roles in protein synthesis. Recent findings have continued to refine our understanding of the function of mTOR in maintaining skeletal muscle mass. mTOR controls the anabolic and catabolic signaling of skeletal muscle mass, resulting in the modulation of muscle hypertrophy and muscle wastage. This review will highlight the fundamental role of mTOR in skeletal muscle growth by summarizing the phenotype of skeletal-specific mTOR deficiency. In addition, the evidence that mTOR is a dual regulator of anabolism and catabolism in skeletal muscle mass will be discussed. A full understanding of mTOR signaling in the maintenance of skeletal muscle mass could help to develop mTOR-targeted therapeutics to prevent muscle wasting.

Keywords: atrophy; hypertrophy; mTOR; sarcopenia; skeletal muscle.

PubMed Disclaimer

Figures

Figure 1

Figure 1

The summary of the regulation of mTORC1 activity in skeletal muscles. Multiple factors and pathways affect mTORC1 activity to regulate skeletal muscle mass. mTORC1 is activated by IGF-I/insulin, mechanical stimulation and amino acids (blue lines) and inhibited by glucocorticoids and myostatin (red lines). Activated mTORC1 increases protein synthesis in skeletal muscle.

Similar articles

Cited by

References

    1. Aguilar V., Alliouachene S., Sotiropoulos A., Sobering A., Athea Y., Djouadi F., et al. . (2007). S6 kinase deletion suppresses muscle growth adaptations to nutrient availability by activating AMP kinase. Cell Metab. 5, 476–487. 10.1016/j.cmet.2007.05.006 - DOI - PubMed
    1. Allen D. L., Cleary A. S., Hanson A. M., Lindsay S. F., Reed J. M. (2010). CCAAT/enhancer binding protein-δ expression is increased in fast skeletal muscle by food deprivation and regulates myostatin transcription in vitro. Am. J. Physiol. Regul. Integr. Compar. Physiol. 299, R1592–R1601. 10.1152/ajpregu.00247.2010 - DOI - PMC - PubMed
    1. Amirouche A., Durieux A. C., Banzet S., Koulmann N., Bonnefoy R., Mouret C., et al. . (2009). Down-regulation of Akt/mammalian target of rapamycin signaling pathway in response to myostatin overexpression in skeletal muscle. Endocrinology 150, 286–294. 10.1210/en.2008-0959 - DOI - PubMed
    1. Barton-Davis E. R., Shoturma D. I., Musaro A., Rosenthal N., Sweeney H. L. (1998). Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc. Natl. Acad. Sci. U.S.A. 95, 15603–15607. 10.1073/pnas.95.26.15603 - DOI - PMC - PubMed
    1. Bentzinger C. F., Romanino K., Cloetta D., Lin S., Mascarenhas J. B., Oliveri F., et al. (2008). Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. Cell Metab. 8, 411–424. 10.1016/j.cmet.2008.10.002 - DOI - PubMed

Publication types

LinkOut - more resources